Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
National NanoTechnology Initiative, http://www.nano.gov/, September 2006
- 2.
ICH Harmonized Tripartite Guideline, Impurities: Guideline for Residual Solvents Q3C (R3)
- 3.
FDA Guideline of General Principles of Process Validation, May 1987
References
Agostiano, A., Catalano, M., Curri, M.L. Della, Monica, M., Manna L., Vasanelli, L. (2000) Synthesis and structural characterization of CDs nanoparticles prepared in four-components “water-in-oil”. microemulsion. Micron. 31, 253–258
Allènmann, E., Gurny, R., Doelker, E. (1993) Drug-loaded nanoparticles-preparation methods and drug targeting issues. Eur. J. Biopharm. 39, 173–191.
Attwood, D. (1994) Microemulsions. In: J Kreuter (eds) Colloidal drug delivery. New York Marcel Dekker
Breen, P.V. (2006) Small-tech big potential. Drug Deliv, November 2006, 30–31
Brigger, I., Dubernet, C., Couvreur, P. (2002) Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54, 631–651
Dearn, A.R. (1995) Atovaquone pharmaceutical compositions. European patent EU 0/075711, August 5
Delie, F., Blanco-Prieto, M.J. (2005) Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 10, 65–80.
Desai, M.P., Labhasetwar, V., Walter, E., Levy, R.J., Amidon, G.L. (1997) The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14, 1568–1573
Fang, J., Stokes, K.L., Wiemann, J., Zhou, W. (2000) Nanocrystalline bismuth synthesized via an in situ polymerization microemulsion process. Mater. Lett. 42, 113–120
Fahmy, T. M. Fong, P.M. Goyal, A., Saltzman, W.M. (2005) Targeted for drug delivery. Nanotoday, August, 18–26
Fendler, J.H. (1994) Membrane-mimetic approach to advanced materials. In Advances in Polymer Science 113, Springer Berlin
Feng, S. (2004) Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev. Med Devices 1, 115–125
Freitas, C., Muller, R.H. (1998) Spray-drying of solid lipid nanoparticles. Eur. J. Pharm and Biopharm. 46, 145–151
Gasco, M.R. (1997) Solid lipid nanospheres from warm microemulsions. Pharm. Tech. Eur. 9, 52–58
Huettenrauch, R. (1984) Molecular pharmaceutics. Part 86. Stability of activated states in solid drug forms. Pharmazie 39, 272
Hu, J., Johnston, K.P., Williams, R.O. (2004) Nanoparticle engineering process for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind. Pharm. 30, 233–245
Jung, T., Kamm, W., Bretenbach, A., Kaiserling, E., Xiao, J.X., Kissel, T. (2000) Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharma. Biopharm. 50, 147–160
Kayser, O., Lemke, A., Hernandez-Trejo, N. (2005) The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotech. 6, 3–5
Kim, G., Nie, S. (2005) Targeted cancer nanotherapy. Nanotoday 28–33
Kipp, J.E. (2004) The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 284, 109–122
Knight, P. (2006) Transforming potential for difficult drugs. Drug Delivery, November 2006, 6–8
Landfester, K. (2001) Polyreactions in miniemulsions Macromol. Rapid Commun. 22, 896–936
Langevin, D. (1991) Microemulsions-interfacial aspects Adv Colloid Interface Sci. 34: 583
Liversidge, G.G., Cundy, K.C. (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. Int. J. Pharm. 125, 91–97
Lockman, P.R., Mumper, R.J., Khan, M.A., Allen, D.D. (2002) Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28.
Mehnert, W., Mader, K. (2001) Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Del. Rev 47, 165–196
Muller, R.H. Jacobs, C., Kayser, O. (2001) Nanosuspension as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47, 3–19
Mumper, R.J. Cui, Z., Oyewumi, M.O. (2003) Nanotemplate engineering of cell-specific nanoparticles. J. Disp. Sci. Tech. 24, 569–588
Moghimi, S.M., Hunter, A.C. (2001) Capture of stealth nanoparticles by body defences. Crit. Rev. Ther. Drug Carrier Sys. 6, 527–550
Oyewumi, M.O., Mumper, R.J. (2002) Gadolinium loaded nanoparticles engineered from microemulsion templates. Drug Dev. Ind. Pharm. 28, 317–328
Panchapakesan, B. (2005) Nanotechnology: Part 2 Tiny Technology-tremendous therapeutic potential. Oncology Issues Nov/Dec 2005
Pikal, M.J. Shah, S., Roy, M.L., Putman, R. (1990) The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure. Int. J. Pharm. 60, 203–217
Rabinow, B.E. (2004) Nanosuspensions in drug delivery. Nat. Rev Drug Discov. 3, 785–796.
Schmidt, C., Bodmeier, R. (1999) Incorporation of polymeric nanoparticles into solid dosage forms. J. Control. Rel. 57, 115–125
Setler, 1995, P. (1999) Identifying new oral technologies to meet your drug delivery needs for the delivery of peptides and proteins and poorly soluble molecules. IIR Limited Drug Delivery Systems, London, March 1999
Sham, J.O., Zhang, Y., Finlay, W.H., Roa, W.H., Lobenberg, R. (2004) Formulation and characterization for aerosol delivery to the lung. Int. J. Pharm. 269, 457–567
Ward, G.H., Schultz, R.K. (1995) Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. Pharm. Res. 12, 773–779
Wissing, S.A., Muller, R.H. (2003) Cosmetic applications for solid lipids nanoparticles (SLN). Int. J. Pharm. 254, 65–68
Wu, N.Z. Da, D., Rudoll, T.L., Needham, D. Whorton, A.R. Dewhirst, M.W. (1993) Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res. 53, 3765–3770
Yi, Y.M., Yang, T.Y., Pan W.M. (1999) Preparation and distribution of 5-fluorouracil I-125 sodium alginate-bovine serum albumin nanoparticles. World J. Gastroenterol. 5, 57–60
Yoo, H.S. Lee, K.H. Oh, J.E., Park, T.G. (2000) In vitro and in vivo antitumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J. Control. Rel. 68, 419–431
Zuidam, N.J., Lee, S.S.L., Crommelin, D.J.A. (1992) Sterilization of liposomes by heat treatment. Pharm. Res. 10, 1591–1596
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Majuru, S., Oyewumi, M.O. (2009). Nanotechnology in Drug Development and Life Cycle Management. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-77668-2_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77667-5
Online ISBN: 978-0-387-77668-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)